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a  b  s  t  r  a  c  t
INTRODUCTION:  As pulmonary  resection  for metastatic  gastric  cancer  has been  rarely  reported  on,  the
role  of  metastasectomy  remains  unclear  in such  settings.  We  reviewed  the  clinicopathological  character-
istics  and  surgical  outcomes  of patients  with  metachronous  pulmonary  metastasis  from  gastric  cancer
(MPMGC)  diagnosed  using  multi-detector  computed  tomography  (MDCT)  who  underwent  pulmonary
resection.
PRESENTATION  OF  CASE:  From  September  2002  to May  2018,  five  patients  underwent  pulmonary  resection
for  MPMGC  at  Shizuoka  Cancer  Center.  All  patients  received  curative  resection  for  initial  gastric  cancer.
Three  patients  received  adjuvant  chemotherapy.  The  median  age  at pulmonary  resection  was  70  years.
The median  disease-free  interval  between  initial  gastrectomy  and  MPMGC  diagnosis  was  41 months.
The  first  site  of recurrence  was  the lung  in all patients.  All  patients  were  diagnosed  as  having  primary
lung  cancer  using  MDCT  before  pulmonary  resection  and  fit the  surgical  indication  for  primary  lung
cancer.  Lobectomy  was  performed  in  three  patients,  while  wedge  resection  was  performed  in  two.  The
median  overall  survival  following  pulmonary  resection  was  79 (range,  18–89)  months.  Two  patients
experienced  recurrence.  While  one  showed  recurrence  in  the  mediastinal  lymph  node,  in the  other  it
was observed  in  the  remnant  lung;  the latter  underwent  repeated  pulmonary  resection  followed  by
systemic  chemotherapy.  Four  patients  survived  for longer  than  4 years  after  pulmonary  resection.
CONCLUSIONS:  Of the  five  patients  with  MPMGC  diagnosed  using  MDCT  who  underwent  pulmonary
resection,  long-term  survival  was achieved  after  pulmonary  resection  in  four.  Thus,  pulmonary  resection
may  be  considered  for those  diagnosed  with  lung  nodules  after  surgery  for  gastric  cancer,  and  who  fit
the  surgical  indication  for primary  lung  cancer.
©  2020  Published  by  Elsevier  Ltd on  behalf  of IJS Publishing  Group  Ltd.  This  is  an  open  access  article
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1. Introduction
Following curative resection for gastric cancer, the most com-
monly observed sites of recurrence are the peritoneum and
lymph nodes, while the most frequently noted site of hematoge-
nous recurrence is the liver, followed by the lungs, brain, and
bones [1–4]. Although the standard treatment for metastatic gas-
tric cancer is systemic chemotherapy, surgical resection for liver
metastasis is considered a treatment option for select patients
according to Japanese gastric cancer treatment guidelines [5].
In our institute, surgical resection is performed for cases with
liver metastasis from gastric cancer as clinical practice, with an
associated median overall survival time of 49 months and 5-
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ear survival rate of 32% [6]. In contrast, the role of surgical
esection for pulmonary metastasis from gastric cancer remains
nclear.
The use of pulmonary metastasectomy has been proposed for
olid tumors, such as sarcomas, adrenal cortical carcinomas and
astrointestinal cancers [7–9]. Although pulmonary resection for
etastatic colorectal cancer is commonly performed in clinical
ractice, this is only based on retrospective studies; no ran-
omized controlled trials have focused on the topic [9,10]. The
n-progress Pulmonary Metastasectomy in Colorectal Cancer trial
11] is the first randomized control trial to be conducted in such
ettings.
Pulmonary metastasis from gastric cancer is normally associ-
ted with carcinomatous lymphangitis, malignant pleural effusion,
umerous lesions, or concomitant metastatic sites [12,13],
hereas solitary pulmonary metastasis from gastric cancer occurs
xtremely rarely. Therefore, pulmonary resection for metastatic
astric cancer has been rarely reported on. Moreover, the surgical
utcomes of this procedure are not satisfactory as per previ-
us reports [14–19], with a recent systematic review showing a
edian overall survival after lung resection of 45 (range, 1–123)
onths, and a median disease-free survival duration of 9 (range,
–65) months [14]. However, that review was based on single-
enter retrospective reports of relatively small sample sizes, and
he diagnostic modalities used for pulmonary metastasis were not
escribed in detail [14–17]. As the efficacy of multi-detector com-
uted tomography (MDCT) for pulmonary tumor diagnosis has
een demonstrated [20], we unified the diagnoses of the present
ases with modern diagnostic technology.
In this report, we present a review of the clinicopatho-
ogical characteristics and surgical outcomes of patients with
etachronous pulmonary metastasis from gastric cancer (MPMGC)
iagnosed using MDCT who underwent pulmonary resection at
hizuoka Cancer Center [21]. Further, we evaluated the significance
f surgical resection for patients with pulmonary nodules following
urgery for gastric cancer.
. Presentation of case
From September 2002 to May  2018, five patients under-
ent pulmonary resection for MPMGC  at Shizuoka Cancer Center.
he collection and analysis of data in this retrospective cohort
tudy were approved by the Institutional Review Board of the
hizuoka Cancer Center (Approval No. 29-J31-30-1-3). Tumor
tage and histological classification were determined according
o the 3rd English edition of the Japanese Classification of Gas-
ric Carcinoma [22] (Table 1). All patients underwent curative
esection for initial gastric cancer. The initial tumor stage was
tage II or III in four patients; however, it was  Stage IA in one.
he histological type of gastric cancer was predominantly well-
ifferentiated adenocarcinoma. The median disease-free interval
DFI) between initial gastrectomy and pulmonary metastasis diag-
osis was 41 (range, 25–56) months. The first site of recurrence
as the lung in all patients. The median interval between ini-
ial gastrectomy and pulmonary resection was 42 (range, 29–59)
onths.
The clinical courses are shown in Fig. 1. Three patients received
djuvant chemotherapy for initial gastric cancer. None of the
atients received chemotherapy for the treatment of pulmonary
etastasis before pulmonary resection.
The characteristics of the pulmonary metastases are shown inable 2. The median age at pulmonary resection was  70 (range,
9–78) years. The Eastern Cooperative Oncology Group perfor-
ance status (PS) was 0 in all patients. All patients were diagnosed
sing MDCT; four were diagnosed as having a single nodule, andrgery Case Reports 73 (2020) 342–346 343
one as having two  nodules (Fig. 2). Preoperative biopsy of the pul-
monary nodules was performed in two patients bronchoscopically,
leading to the diagnosis of adenocarcinoma; in the other patients,
biopsy was not performed because of the nodule location. As it was
difficult to differentiate the MPMGC  from the primary lung can-
cer histologically and radiologically, all patients were diagnosed as
having primary lung cancer before surgery.
Data on the surgical procedures used and pathological diag-
noses are shown in Table 3. Although frozen section examinations
were conducted on specimens obtained from four patients dur-
ing surgery, only two  patients received an MPMGC  diagnosis.
Lobectomy was  performed in three patients, while wedge resec-
tion was performed in two; those two patients received limited
resection according to the diagnosis of MPMGC  by frozen section
examination during surgery. The median surgery time was 226
(range, 67–305) minutes, and the median bleeding amount was
14 (range, 0–68) g. The median postoperative stay duration was
8 (range, 7–20) days, and no postoperative complications were
observed.
The pulmonary nodules were histologically diagnosed as
MPMGC  with morphological similarity to the primary gastric can-
cer. In addition, immunohistochemistry was performed by staining
thyroid transcription factor-1 (TTF-1) for diagnosis confirmation;
all patients were negative for TTF-1. One patient had lymph node
metastasis at the hilum. Although there was a divergence in the
diagnosis of the number of nodules in one patient, the radiologi-
cal and pathological diagnoses were almost identical regarding the
number of metastases and nodule diameters.
The median overall survival duration following pulmonary
resection was  79 (range, 18–89) months (Table 4). Three patients
received chemotherapy after pulmonary resection and the other
two did not due to patient preference. Two patients showed recur-
rence. One experienced recurrence in the mediastinal lymph node
during systemic chemotherapy following pulmonary resection.
Although the patient continued chemotherapy after recurrence
with a regimen change, he died due to disease progression. The
other patient showed recurrence in the remnant lung, underwent
repeated pulmonary resection followed by systemic chemother-
apy, and achieved long-term survival. Of the five patients, four
survived for longer than 4 years following pulmonary resection.
3. Discussions
In this report, we  present the cases of five patients who under-
went pulmonary resection for MPMGC, demonstrating remarkably
better survival values following resection compared to previous
reports [14–18]. All patients showed good PS and DFI values, and
the preoperative diagnosis was primary lung cancer across all
cases. Three patients were pathologically diagnosed as having a
single lesion and achieved long disease-free survival, while two
with multiple lesions showed recurrence after surgery; one patient
underwent repeated resection and achieved long-term survival.
Pulmonary resection for MPMGC  could be the treatment option
for select patients. According to current treatment guidelines, the
standard treatment for MPMGC  is systemic chemotherapy [5];
however, the associated survival outcomes are not satisfactory. The
median OS in patients with pulmonary metastasis is 4 months, and
even in those treated with chemotherapy, the 5-year survival rate
is only 2–4% [12,23]. Pulmonary resection for MPMGC  has been
rarely reported on owing to its low frequency of use; additionally,
it has previously been considered futile [19]. Recently, however,
several reports have demonstrated long-term survival following
pulmonary resection for MPMGC  [15,24]; therefore, pulmonary
metastasectomy has been reconsidered as a treatment option in
such settings.
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Table 1





















1 67 Male DG R0 IIA differentiated 41 Lung 42
2  54 Female TG R0 IIA undifferentiated 56 Lung 59
3  63 Male TG R0 IIIA differentiated 27 Lung 30
4  67 Male DG R0 IA differentiated 25 Lung 29
5  74 Male DG R0 IIA differentiated 47 Lung 49
DFI, disease-free interval; DG, distal gastrectomy, TG, total gastrectomy.
Fig. 1. Clinical courses of the five patients.
Table 2

















1 70 0 Apical segment of right upper lobe 1 2.8 Primary > Meta + adenocarcinoma
2  59 0 Apical segment of left upper lobe 1 1.4 Primary > Meta – –
3  65 0 Apical segment of right upper lobe 1 1.0 Primary > Meta – –
4  70 0 Apical segment of right upper lobe
lateral segment of right lower lobe
2 1.0, 0.8 Primary or Meta – –
5  78 0 Apical segment of right upper lobe 1 1.8 Primary or Meta + adenocarcinoma
PS, performance status.
Fig. 2. Multi-detector computed tomography showed pulmonary nodules. (a) In patient 2, the nodule was found at the apical segment of the left upper lobe and was
considered to be primary lung cancer rather than metachronous pulmonary metastasis from gastric cancer (MPMGC). (b) On the other hand, in patient 3, the nodule was
found  at the apical segment of the right upper lobe, making it difficult to differentiate between MPMGC and primary lung cancer.
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Table  3













1 Lobectomy + systematic nodal dissection – – 3 4.0 Hilar
2  Lobectomy + systematic nodal dissection + adenocarcinoma 1 1.2 None
3  Lobectomy + systematic nodal dissection + adenocarcinoma 1 2.0 None
4  Wedge resection + metastatic gastric cancer 2 1.0 None
5  Wedge resection + metastatic gastric cancer 1 1.7 None
LN, lymph node.
Table 4















1 Mediastinal LN 6 18 61 Dead
2  Disease-free 79 79 138 Alive
3  Disease-free 89 89 120 Alive









































5  Disease-free 49 
FS, disease-free survival; OS, overall survival; LN lymph node.
Although previous systematic reviews were conducted with
he aim of selecting patients in whom long-term survival can be
chieved by pulmonary metastasectomy, they failed to demon-
trate any statistically significant prognostic factors [14,15].
owever, those studies consistently reported a trend for better sur-
ival in cases with a single metastasis and long DFI [7,14,15,17].
hese studies may  have failed to show significant prognostic fac-
ors in part due to the wide range of study periods that were
ncluded, and the diagnostic modalities used for pulmonary metas-
asis. MDCT has greater sensitivity than conventional computed
omography (CT) in the detection of small lesions [20]. In the
resent report, all tumors were diagnosed using modern diagnos-
ic technologies, and the diagnoses were almost identical to those
chieved through pathological study. Our patients achieved bet-
er survival values than those in previous studies as we  diagnosed
umors at an early stage and did not miss the presence of small
uplicate lesions using sensitive MDCT. Although no study has pre-
iously demonstrated a diagnostic modality for metastatic gastric
ancer or compared radiological and pathological diagnoses, there
s a chance that small multiple metastases were presented and
issed. In our study, the patient with a single pulmonary metasta-
is diagnosed using modern diagnostic technology who showed a
ong DFI after surgery for gastric cancer may  be considered a good
andidate for metastasectomy.
It may  be reasonable to consider pulmonary resection for
atients with pulmonary nodules after surgery for gastric cancer
ho fit the surgical indication for primary lung cancer. All the
atients in this study were clinically diagnosed with primary lung
ancer before pulmonary resection; this is consistent with previous
eports that stated that lung cancer is among frequently presenting
econdary malignancies following gastric cancer surgery [25], and
hat the lungs are less commonly the initial sites of postoperative
astric cancer recurrence [26]. Nakamura et al. reported difficulties
n the performance of differential histological diagnosis between
rimary lung cancer and metastasis; thus, surgical resection is the
nly accurate evaluation method [27]. With regards to the surgi-
al procedures used for metastatic gastric cancer, previous studies
ailed to show the advantages of lobectomy over limited resection
14,15]. In our study, two patients underwent wedge resection;
ne survived without recurrence while the other showed recur-
ence in the remnant lung. Although a very small number of cases49 96 Alive
were included in this present report, even limited resection may
aid in the achievement of long disease-free durations in cases with
a single lesion. These findings suggest that when a lung tumor is
observed after surgery for gastric cancer, it is reasonable to indicate
pulmonary resection according to the primary lung cancer. Further-
more, even if the tumor is diagnosed as MPMGC  pre-operatively or
during surgery, limited resection may  be sufficient.
Iida et al. proposed that metastases to the lung and upstream
organs, or liver, can be regarded as “semilocal” disease, explain-
ing the favorable outcomes after metastasectomy [28]. Therefore,
pulmonary metastasectomy still has the potential to yield better
survival values as long as the lung’s defense system is function-
ing and is capable of preventing tumor cells from spreading to the
downstream organs. As previous studies have reported, the most
commonly observed site of recurrence after pulmonary metasta-
sectomy is the lung, and patients with multiple lesions have a high
risk of recurrence. However, some patients achieve long-term sur-
vival after repeat metastasectomy [14,29]. Thus, careful follow-up
using periodic CT for early detection is strongly recommended after
pulmonary metastasectomy, especially for patients with patholog-
ically proven multiple lesions.
The present study has a few limitations. It was a retrospective
study performed in a single institution; thus, the study population
was relatively small. Although this study was underpowered, we
only included patients who  were diagnosed using modern diagnos-
tic technology. In the future, large-scale multicenter studies should
be performed to investigate pulmonary resection for MPMGC  diag-
nosed using MDCT.
4. Conclusions
In this report, we presented our experiences with five patients
in whom MPMGC  was  diagnosed using MDCT and who under-
went pulmonary resection, and we observed survival outcomes
that were remarkably better than those in previous reports. Pul-
monary resection may  be considered for patients diagnosed with
pulmonary nodules after surgery for gastric cancer, who fit the
surgical indications for primary lung cancer; moreover, in select
patients, such as those with good PS and DFI values, long-term sur-
vival may  be achieved even if the nodule is diagnosed as MPMGC
post-operatively.
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